Hiroshi Nakashima
Overview
Explore the profile of Hiroshi Nakashima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
199
Citations
3710
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakashima H, Kabe I, Iwasawa S, Miyoshi Y, Hashimoto I, Yoshioka N, et al.
Environ Occup Health Pract
. 2025 Mar;
6(1).
PMID: 40061359
Objectives: For occupational health staff, the health status of the worksite is an important matter, and a single index for presenting this health status is desired. We applied a stroke...
2.
Ishibashi T, Inoue R, Nakashima H, Emi K
Jpn J Ophthalmol
. 2025 Jan;
69(1):66-73.
PMID: 39847184
Purpose: To provide insights into the transscleral removal technique for subretinal proliferative tissues (SRP). Study Design: Retrospective, single-center case series. Methods: Patients who underwent transscleral removal of SRP during vitrectomy...
3.
Mehretie S, Inoue S, Hayashi T, Nakashima H, Panintorn P, Ninomiya K, et al.
Food Chem
. 2024 Aug;
461:140894.
PMID: 39163722
Fruit maturity at harvest is a major factor in determining its quality. In this study, external skin color of grape has been utilized to predict their chemical content and, in...
4.
Noh M, Kang J, Miller A, Nguyen G, Huang M, Shim J, et al.
Neuro Oncol
. 2024 Jun;
26(9):1602-1616.
PMID: 38853689
Background: The FDA approval of oncolytic herpes simplex-1 virus (oHSV) therapy underscores its therapeutic promise and safety as a cancer immunotherapy. Despite this promise, the current efficacy of oHSV is...
5.
Ling A, Solomon I, Landivar A, Nakashima H, Woods J, Santos A, et al.
Nature
. 2023 Oct;
623(7985):157-166.
PMID: 37853118
Immunotherapy failures can result from the highly suppressive tumour microenvironment that characterizes aggressive forms of cancer such as recurrent glioblastoma (rGBM). Here we report the results of a first-in-human phase...
6.
Liu J, Piranlioglu R, Ye F, Shu K, Lei T, Nakashima H
Front Cell Infect Microbiol
. 2023 May;
13:1141034.
PMID: 37234776
Glioblastoma is a highly aggressive form of brain cancer characterized by the abundance of myeloid lineage cells in the tumor microenvironment. Tumor-associated macrophages and microglia (TAM) and myeloid-derived suppressor cells...
7.
Kawai T, Nakashima H, Washimi K, Yokose T, Matsuo T, Nakayama M, et al.
Hum Pathol
. 2023 Apr;
136:105-113.
PMID: 37023867
Liposarcoma rarely occurs in the pleura or thoracic cavity, and few reports appear in the literature. We hypothesized that combining clinicopathologic, immunohistochemical, and fluorescence in situ hybridization methods would allow...
8.
Ogasawara T, Mukaino M, Matsuura H, Aoshima Y, Suzuki T, Togo H, et al.
Front Physiol
. 2023 Feb;
14:1094946.
PMID: 36776969
Acceleration sensors are widely used in consumer wearable devices and smartphones. Postures estimated from recorded accelerations are commonly used as features indicating the activities of patients in medical studies. However,...
9.
Yao Y, Wang J, Liu Y, Qu Y, Wang K, Zhang Y, et al.
Nat Biomed Eng
. 2022 Oct;
6(11):1257-1271.
PMID: 36217021
The development of gene therapies for the treatment of diseases of the central nervous system has been hindered by the limited availability of adeno-associated viruses (AAVs) that efficiently traverse the...
10.
Mukaino M, Ogasawara T, Matsuura H, Aoshima Y, Suzuki T, Furuzawa S, et al.
BMC Sports Sci Med Rehabil
. 2022 Jun;
14(1):104.
PMID: 35689292
Background: Recent advancements in wearable technology have enabled easy measurement of daily activities, potentially applicable in rehabilitation practice for various purposes such as maintaining and increasing patients' activity levels. In...